This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Chukwuma Agu
CEO at ABS Biotechnologies GmbH
Speaker

Profile

Dr. Chukwuma Agu is an accomplished leader in stem cell biology and regenerative medicine with over 15 years of experience across academic, clinical, and biotech sectors. He previously served as Head of the Stem Cell Core Facility at the Institute of Molecular Biotechnology (IMBA) in Vienna and held senior scientific leadership roles at the Wellcome Trust Sanger Institute, where he led transformative programs in induced pluripotent stem cell (iPSC) technologies, translational research, and large-scale biomanufacturing.

Dr. Agu combines deep scientific expertise with strategic business acumen, holding an MBA in Healthcare from Coventry University, UK. As CEO of ABS Biotechnologies, he drives international collaborations and oversees the development of scalable, inclusive stem cell platforms that advance predictive drug testing and drug development. His work is at the forefront of creating human-relevant, ethically responsible solutions that accelerate scientific discovery and therapeutic innovation.

At this event